Caribou Biosciences, Inc. Increase (Decrease) in Other Operating Liabilities
Caribou Biosciences, Inc. (CRBU) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2024-03-11
- Caribou Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-12-31 was $0.00.
- Caribou Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-09-30 was $0.00.
- Caribou Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-06-30 was $0.00.
- Caribou Biosciences, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was $0.00.
- Caribou Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was $0.00.
- Caribou Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was -$15.00K.
- Caribou Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2021 was -$162.00K.
- Caribou Biosciences, Inc. increase (decrease) in other operating liabilities for fiscal 2020 was -$247.00K, a 158.12% decline from fiscal 2019.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $0.00 derived: sum of 2 quarters · filed 2024-03-11 | $0.00 derived: sum of 3 quarters · filed 2024-03-11 | $0.00 10-K · filed 2024-03-11 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-03-11 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-03-11 | $0.00 derived: sum of 4 quarters · filed 2024-03-11 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-11 | $0.00 derived: sum of 3 quarters · filed 2024-03-11 | -$7.00K derived: sum of 4 quarters · filed 2024-03-11 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $0.00 derived: sum of 2 quarters · filed 2024-03-11 | -$7.00K derived: sum of 3 quarters · filed 2024-03-11 | -$15.00K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$7.00K derived: sum of 2 quarters · filed 2023-11-07 | -$15.00K 10-Q · filed 2023-11-07 | -$177.00K derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$15.00K 10-Q · filed 2023-08-08 | -$177.00K derived: sum of 3 quarters · filed 2023-08-08 | -$163.00K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$8.00K 10-Q · filed 2023-05-09 | -$170.00K derived: sum of 2 quarters · filed 2023-05-09 | -$156.00K derived: sum of 3 quarters · filed 2023-05-09 | -$162.00K derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | -$162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$148.00K derived: sum of 2 quarters · filed 2023-03-09 | -$154.00K derived: sum of 3 quarters · filed 2023-03-09 | -$162.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $8.00K derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$22.00K 10-Q · filed 2021-11-09 | $184.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$14.00K 10-Q · filed 2022-08-09 | $170.00K derived: sum of 3 quarters · filed 2022-08-09 | $218.00K derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$8.00K 10-Q · filed 2022-05-09 | $176.00K derived: sum of 2 quarters · filed 2022-05-09 | $224.00K derived: sum of 3 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $232.00K derived: sum of 2 quarters · filed 2022-03-21 | -$247.00K 10-K · filed 2022-03-21 | ||
| 2020-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$431.00K 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | -$479.00K 10-Q · filed 2021-09-02 | ||||
| 2019-12-31 | $425.00K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |